Effects of cigarette reduction on cardiovascular risk factors and subjective measures

Chest

Volumn 128, Issue 4, 2005, Pages 2528-2537

  Hatsukami, Dorothy K ^a   Kotlyar, Michael ^b   Allen, Sharon ^a   Jensen, Joni ^a   Li, Shelby ^a   Le, Chap ^a   Murphy, Sharon ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Biomarkers; Cardiovascular risk factors; Cigarette reduction; Harm reduction

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CARBON MONOXIDE; CHOLESTEROL; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NICOTINE; NICOTINE GUM; TRIACYLGLYCEROL;

ABSTINENCE; ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHROCYTE COUNT; FEMALE; HEART RATE; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; LEUKOCYTE COUNT; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; PATIENT COUNSELING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RISK REDUCTION; SELF HELP; SMOKING CESSATION; TOBACCO DEPENDENCE; TREATMENT OUTCOME;

EID: 27144438524     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.4.2528     Document Type: Article

References (29)

1. Stratton K, Shetty P, Wallace R, et al. Clearing the smoke: assessing the science base for tobacco harm reduction. Washington, DC: Institute of Medicine National Academy Press, 2001
2. Hatsukami D, Slade J, Benowitz N, et al. Reducing tobacco harm: research challenges and issues. Nicotine Tob Res 2002; 4:S89-S101
3. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 1989; 298:784-788
4. Allen SS, Hatsukami D, Gorsline J. Cholesterol changes in smoking cessation using the transdermal nicotine system: Transdermal Nicotine Study Group. Prev Med 1994; 23:190-196
5. Bolliger CT, Zellweger JP, Danielsson T, et al. Influence of long-term smoking reduction on health risk markers and quality of life. Nicotine Tob Res 2002; 4:433-439
6. Eliasson B, Hjalmarson A, Kruse E, et al. Effect of smoking reduction and cessation on cardiovascular risk factors. Nicotine Tob Res 2001; 3:249-255
7. Etter JF, Laszlo E, Zellweger JP, et al. Nicotine replacement to reduce cigarette consumption in smokers who are unwilling to quit: a randomized trial. J Clin Psychopharmacol 2002; 22:487-495
8. Bolliger CT, Zellweger JP, Danielsson T, et al. Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety. BMJ 2000; 321:329-333
9. Hurt RD, Croghan GA, Wolter TD, et al. Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler. Nicotine Tob Res 2000; 2:327-336
10. Hecht SS, Murphy SE, Carmella SG, et al. Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen. J Natl Cancer Inst 2004; 96:107-115
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington, DC: American Psychiatric Association, 1994
12. Hecht SS, Carmella SG, Chen M, et al. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Res 1999; 59:590-596
13. Jacob P III, Yu L, Liang G, et al. Gas chromatographic-mass spectrometric method for determination of anabasine, anatabine and other tobacco alkaloids in urine of smokers and smokeless tobacco users. J Chromatogr 1993; 619:49-61
14. Jacob P III, Hatsukami D, Severson H, et al. Anabasine and anatabine as biomarkers for tobacco use during nicotine replacement therapy. Cancer Epidemiol Biomarkers Prev 2002; 11:1668-1673
15. Cohen J. Statistical power analysis for the behavioral sciences. New York, NY: Academic Press, 1988
16. van Berkel TF, Boersma H, Roos-Hesselink JW, et al. Impact of smoking cessation and smoking interventions in patients with coronary heart disease. Eur Heart J 1999; 20:1773-1782
17. Burns DM. Epidemiology of smoking-induced cardiovascular disease. Prog Cardiovasc Dis 2003; 46:11-29
18. Nieto FJ, Szklo M, Folsom AR, et al. Leukocyte count correlates in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 1992; 136:525-537
19. Petitti DB, Kipp H. The leukocyte count: associations with intensity of smoking and persistence of effect after quitting. Am J Epidemiol 1986; 123:89-95
20. Sunyer J, Munoz A, Peng Y, et al. Longitudinal relation between smoking and white blood cells. Am J Epidemiol 1996; 144:734-741
21. Bazzano LA, He J, Muntner P, et al. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med 2003; 138:891-897
22. Benowitz NL. Cigarette smoking and cardiovascular disease: Pathophysiology and implications for treatment. Prog Cardiovasc Dis 2003; 46:91-111
23. Tsiara S, Elisaf M, Mikhailidis DP. Influence of smoking on predictors of vascular disease. Angiology 2003; 54:507-530
24. Green MS, Harari G. A prospective study of the effects of changes in smoking habits on blood count, serum lipids and lipoproteins, body weight and blood pressure in occupationally active men: the Israeli CORDIS Study. J Clin Epidemiol 1995; 48:1159-1166
25. Ludviksdottir D, Blondal T, Franzon M, et al. Effects of nicotine nasal spray on atherogenic and thrombogenic factors during smoking cessation. J Intern Med 1999; 246:61-66
26. Van Tiel E, Peeters PH, Smit HA, et al. Quitting smoking may restore hematological characteristics within five years. Ann Epidemiol 2002; 12:378-388
27. Godtfredsen NS, Osler M, Vestbo J, et al. Smoking reduction, smoking cessation, and incidence of fatal and non-fatal myocardial infarction in Denmark 1976-1998: a pooled cohort study. J Epidemiol Community Health 2003; 57:412-416
28. Hatsukami DK, Rennard S, Patel MK, et al. Effects of sustained-release bupropion among persons interested in reducing but not quitting smoking. Am J Med 2004; 116:151-157
29. Carpenter M, Hughes J, Keely J. Effect of smoking reduction on later cessation: a pilot experimental study. Nicotine Tob Res 2003; 5:155-162